Ami Organics Limited (AMIORG) - Total Liabilities

Latest as of March 2025: Rs2.29 Billion INR ≈ $24.79 Million USD

Based on the latest financial reports, Ami Organics Limited (AMIORG) has total liabilities worth Rs2.29 Billion INR (≈ $24.79 Million USD) as of March 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Ami Organics Limited liquidity resilience to evaluate the company's liquid asset resilience ratio.

Ami Organics Limited - Total Liabilities Trend (2014–2025)

This chart illustrates how Ami Organics Limited's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Ami Organics Limited total assets.

Ami Organics Limited Competitors by Total Liabilities

The table below lists competitors of Ami Organics Limited ranked by their total liabilities.

Company Country Total Liabilities
Jaiprakash Power Ventures Limited
NSE:JPPOWER
India Rs-127.32 Billion
ProPetro Holding Corp
NYSE:PUMP
USA $420.74 Million
Ramsay Generale De Sante
PA:GDS
France €5.41 Billion
Reysas Tasimacilik ve Lojistik Ticaret AS
IS:RYSAS
Turkey TL13.23 Billion
Akasha Wira International Tbk
JK:ADES
Indonesia Rp516.28 Billion
Hunan Huakai Cultural and Creative Co Ltd
SHE:300592
China CN¥1.76 Billion
Keystone Reit Ltd
TA:KSTN
Israel ILA1.91 Billion
SFA Semicon Co. Ltd
KQ:036540
Korea ₩97.95 Billion

Liability Composition Analysis (2014–2025)

This chart breaks down Ami Organics Limited's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See Ami Organics Limited balance sheet quality to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 3.91 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio N/A Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.17 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.15 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Ami Organics Limited's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Ami Organics Limited (2014–2025)

The table below shows the annual total liabilities of Ami Organics Limited from 2014 to 2025.

Year Total Liabilities Change
2025-03-31 Rs2.29 Billion
≈ $24.79 Million
-44.53%
2024-03-31 Rs4.13 Billion
≈ $44.68 Million
+138.84%
2023-03-31 Rs1.73 Billion
≈ $18.71 Million
+26.62%
2022-03-31 Rs1.37 Billion
≈ $14.77 Million
-44.54%
2021-03-31 Rs2.46 Billion
≈ $26.64 Million
+105.15%
2020-03-31 Rs1.20 Billion
≈ $12.99 Million
-8.29%
2019-03-31 Rs1.31 Billion
≈ $14.16 Million
+33.76%
2018-03-31 Rs978.86 Million
≈ $10.59 Million
+39.68%
2017-03-31 Rs700.79 Million
≈ $7.58 Million
+7.87%
2016-03-31 Rs649.65 Million
≈ $7.03 Million
+46.40%
2015-03-31 Rs443.74 Million
≈ $4.80 Million
+58.84%
2014-03-31 Rs279.37 Million
≈ $3.02 Million
--

About Ami Organics Limited

NSE:AMIORG India Specialty Chemicals
Market Cap
$1.18 Billion
Rs108.67 Billion INR
Market Cap Rank
#8223 Global
#407 in India
Share Price
Rs1327.40
Change (1 day)
+0.00%
52-Week Range
Rs1327.40 - Rs1327.40
All Time High
Rs2626.70
About

Acutaas Chemicals Limited engages in the research and development, manufacture, and sale of pharmaceutical intermediates in India and internationally. The company offers pharma intermediates for use in regulated and generic active pharmaceutical ingredients for anti-retroviral, anti-inflammatory, anti-psychotic, anti-cancer, anti-Parkinson's, antidepressant, and anticoagulant applications, as wel… Read more